Next Century Growth Investors LLC Novo Nordisk A S Transaction History

Next Century Growth Investors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $2.02 Million - $2.42 Million	-16,451 Reduced 55.29%	13,303 $1.9 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $40,435 - $53,824	396 Added 1.35%	29,754 $3.82 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $267,553 - $321,411	-3,048 Reduced 9.41%	29,358 $3.04 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $713,060 - $1.56 Million	7,841 Added 31.92%	32,406 $2.95 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $910,611 - $1.01 Million	-5,838 Reduced 19.2%	24,565 $3.98 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $92,373 - $111,079	-698 Reduced 2.24%	30,403 $4.84 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $38,558 - $50,884	-376 Reduced 1.19%	31,101 $4.21 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $25,820 - $31,688	271 Added 0.87%	31,477 $3.14 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $3.22 Million - $3.8 Million	31,206 New	31,206 $3.48 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.